Peskind E - Search Results

1

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ. Zhang J, et al. Among authors: peskind e. J Alzheimers Dis. 2005 Apr;7(2):125-33; discussion 173-80. doi: 10.3233/jad-2005-7205. J Alzheimers Dis. 2005. PMID: 15851850

2

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

Peskind ER, Wingerson D, Murray S, Pascualy M, Dobie DJ, Le Corre P, Le Verge R, Veith RC, Raskind MA. Peskind ER, et al. Arch Gen Psychiatry. 1995 Sep;52(9):774-82. doi: 10.1001/archpsyc.1995.03950210068012. Arch Gen Psychiatry. 1995. PMID: 7654129 Clinical Trial.

3

Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma.

Peskind ER, Wingerson D, Pascualy M, Thal L, Veith RC, Dorsa DM, Bodenheimer S, Raskind MA. Peskind ER, et al. Biol Psychiatry. 1995 Oct 15;38(8):532-8. doi: 10.1016/0006-3223(94)00377-F. Biol Psychiatry. 1995. PMID: 8562665

4

Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans.

Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Schwartz MW, et al. Among authors: peskind e. Nat Med. 1996 May;2(5):589-93. doi: 10.1038/nm0596-589. Nat Med. 1996. PMID: 8616722

5

Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration.

Elrod R, Peskind ER, DiGiacomo L, Brodkin KI, Veith RC, Raskind MA. Elrod R, et al. Among authors: peskind er. Am J Psychiatry. 1997 Jan;154(1):25-30. doi: 10.1176/ajp.154.1.25. Am J Psychiatry. 1997. PMID: 8988954

6

Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.

Peskind ER, Leverenz J, Farlow MR, Ito RK, Provow SA, Siegel RS, Cleveland M, Morgan CH, Pandian MR, Corbin S, Nochlin D, Schellenberg GD, Raskind MA, Wagner SL. Peskind ER, et al. Alzheimer Dis Assoc Disord. 1997 Dec;11(4):201-6. Alzheimer Dis Assoc Disord. 1997. PMID: 9437437

7

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr. Craft S, et al. Among authors: peskind e. Neurology. 1998 Jan;50(1):164-8. doi: 10.1212/wnl.50.1.164. Neurology. 1998. PMID: 9443474

8

Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging.

Peskind ER, Elrod R, Dobie DJ, Pascualy M, Petrie E, Jensen C, Brodkin K, Murray S, Veith RC, Raskind MA. Peskind ER, et al. Neuropsychopharmacology. 1998 Dec;19(6):465-71. doi: 10.1016/S0893-133X(98)00054-2. Neuropsychopharmacology. 1998. PMID: 9803422 Clinical Trial.

9

Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.

Raskind MA, Peskind ER, Holmes C, Goldstein DS. Raskind MA, et al. Among authors: peskind er. Biol Psychiatry. 1999 Sep 15;46(6):756-65. doi: 10.1016/s0006-3223(99)00008-6. Biol Psychiatry. 1999. PMID: 10494443

10

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

Peskind ER, Griffin WS, Akama KT, Raskind MA, Van Eldik LJ. Peskind ER, et al. Neurochem Int. 2001 Nov-Dec;39(5-6):409-13. doi: 10.1016/s0197-0186(01)00048-1. Neurochem Int. 2001. PMID: 11578776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters